Profarma Distribuidora de Produtos Farmacêuticos S.A (PFRM3) - Total Liabilities
Based on the latest financial reports, Profarma Distribuidora de Produtos Farmacêuticos S.A (PFRM3) has total liabilities worth R$3.96 Billion BRL (≈ $777.76 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Profarma Distribuidora de Produtos Farma to assess how effectively this company generates cash.
Profarma Distribuidora de Produtos Farmacêuticos S.A - Total Liabilities Trend (2003–2024)
This chart illustrates how Profarma Distribuidora de Produtos Farmacêuticos S.A's total liabilities have evolved over time, based on quarterly financial data. Check PFRM3 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Profarma Distribuidora de Produtos Farmacêuticos S.A Competitors by Total Liabilities
The table below lists competitors of Profarma Distribuidora de Produtos Farmacêuticos S.A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sinmag Equipment
TWO:1580
|
Taiwan | NT$1.05 Billion |
|
Elme Communities
NYSE:ELME
|
USA | $777.68 Million |
|
Lippo Cikarang Tbk
JK:LPCK
|
Indonesia | Rp4.50 Trillion |
|
Mycenax Biotech
TWO:4726
|
Taiwan | NT$1.69 Billion |
|
Gem Terminal Industry Co Ltd
TW:2460
|
Taiwan | NT$2.99 Billion |
|
AMA Group Ltd
AU:AMA
|
Australia | AU$649.09 Million |
|
Hi-Clearance
TWO:1788
|
Taiwan | NT$2.03 Billion |
|
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS Class A
IS:KRDMA
|
Turkey | TL35.63 Billion |
Liability Composition Analysis (2003–2024)
This chart breaks down Profarma Distribuidora de Produtos Farmacêuticos S.A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Profarma Distribuidora de Produtos Farma (PFRM3) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.29 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.08 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.86 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.70 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Profarma Distribuidora de Produtos Farmacêuticos S.A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Profarma Distribuidora de Produtos Farmacêuticos S.A (2003–2024)
The table below shows the annual total liabilities of Profarma Distribuidora de Produtos Farmacêuticos S.A from 2003 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | R$4.03 Billion ≈ $790.84 Million |
+18.58% |
| 2023-12-31 | R$3.40 Billion ≈ $666.93 Million |
+19.08% |
| 2022-12-31 | R$2.85 Billion ≈ $560.07 Million |
+11.63% |
| 2021-12-31 | R$2.56 Billion ≈ $501.73 Million |
+9.94% |
| 2020-12-31 | R$2.33 Billion ≈ $456.37 Million |
+6.75% |
| 2019-12-31 | R$2.18 Billion ≈ $427.51 Million |
+16.57% |
| 2018-12-31 | R$1.87 Billion ≈ $366.73 Million |
-0.24% |
| 2017-12-31 | R$1.87 Billion ≈ $367.63 Million |
-4.08% |
| 2016-12-31 | R$1.95 Billion ≈ $383.27 Million |
+21.00% |
| 2015-12-31 | R$1.61 Billion ≈ $316.74 Million |
+41.68% |
| 2014-12-31 | R$1.14 Billion ≈ $223.56 Million |
-5.61% |
| 2013-12-31 | R$1.21 Billion ≈ $236.86 Million |
+40.41% |
| 2012-12-31 | R$859.67 Million ≈ $168.68 Million |
+24.29% |
| 2011-12-31 | R$691.65 Million ≈ $135.71 Million |
+25.37% |
| 2010-12-31 | R$551.69 Million ≈ $108.25 Million |
+4.78% |
| 2009-12-31 | R$526.50 Million ≈ $103.31 Million |
+15.80% |
| 2008-12-31 | R$454.66 Million ≈ $89.21 Million |
-5.43% |
| 2007-12-31 | R$480.76 Million ≈ $94.33 Million |
+29.21% |
| 2006-12-31 | R$372.09 Million ≈ $73.01 Million |
+6.09% |
| 2005-12-31 | R$350.73 Million ≈ $68.82 Million |
+30.55% |
| 2004-12-31 | R$268.65 Million ≈ $52.71 Million |
+24.48% |
| 2003-12-31 | R$215.82 Million ≈ $42.35 Million |
-- |
About Profarma Distribuidora de Produtos Farmacêuticos S.A
Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution of pharmaceutical products in Brazil. It provides pharmaceutical, personal hygiene, and beauty products. The company operates retail stores under the Drogasmil, Farmalife, Drogarias Tamoio and Drogaria Rosário brands. Profarma Distribuidora de Produtos Farmacêuticos S.A. was incorpor… Read more